Appointed as Director on 31 December 2007, Mr Wang is the Executive
Chairman and CEO, and the founder of the Group. He has more than 20
years of experience in the animal drugs industry. Mr Wang is responsible
for the strategic planning and overall management and operations of the
Group and also oversees its R&D activities. Prior to establishing the Group
in 1996, he was a researcher and head of laboratory of Beijing Science
Committee Experimental Animal Research Centre from 1986 to 1996. He
holds a Bachelor Degree in Veterinary Medicine from Hebei Agriculture
University which he obtained in 1983 and a Masters in Veterinary Medicine
from Shenyang Agriculture University which he obtained in 1986. Mr Wang
will retire in accordance with the Company’s Bye-Laws, and being eligible,
offers himself for re-election at the forthcoming annual general meeting.
Deputy CEO:
Mr Sun Jin Guo
Appointed as Director on 31 December 2007, Mr Sun is the Group’s Deputy
CEO and has been with the Group since 1999. He assists the CEO in the
overall management and operations of the Group. He is also responsible for,
inter alia, corporate development works focusing on new business ventures,
mergers and acquisitions, special projects, feasibility studies and public
relations of the Group. Prior to joining the Group, Mr Sun was the regional
sales manager of Hebei Kexing Animal Drugs Co. Ltd, a company principally
engaged in animal drugs and additives. He holds a Bachelor Degree in
Farming from Hebei Agriculture University which he obtained in 1998.
Independent Director:
Mr Joshua Ong Kian Guan
Appointed as Independent Director on 31 December 2007, Mr Ong chairs
the Audit Committee and is a member of the Remuneration and Nominating
Committees. He has more than 17 years of professional experience. He has
practiced as a public accountant since late 2004, and is now a partner with
Baker Tilly TFWLCL. In the course of his work, Mr Ong specialises in the audits
of public listed companies and companies seeking to list in Singapore,
financial due diligence and outsourced internal audit assignments. He is
currently an independent director and the audit committee chairman of
several other public companies on SGX.
Independent Director:
Mdm Feng Jing Lan
Appointed as Independent Director on 31 December 2007, Madam Feng chairs the
Nominating Committee and is a member of the Audit and Remuneration Committees.
She is the chairperson of the China Animal Health Products Association, an association
principally responsible for overseeing the production of animal drugs in the PRC, inspection
of the daily operations of enterprises in the industry and analysis of the production and
operating conditions of the industry. Prior to her appointment in the China Animal Health
Products Association in 2000, she was the vice-division head and later division head of the
Veterinary Medicine Division of the Farming Bureau of the Ministry of Agriculture of PRC
(MOA) between 1982 and 1989. From 1989 to 1994, she was the vice station head of the
National Farming and Veterinary Medicine of the MOA. Between 1994 and 2000, she was the
vice head and supervisor of the Farming Bureau of the MOA. She holds a Bachelor Degree in
Veterinary Medicine from Dongbei Agriculture College (now known as Dongbei Agriculture
University) which she obtained in 1964.
Independent Director:
Mr Wong Gang
Appointed as Independent Director on 31 December 2007, Mr Wong chairs the Remuneration
Committee and is a member of the Audit and Nominating Committees. A partner in law
firm Shook Lin & Bok LLP since 2002, he has more than 12 years’ professional experience
advising on a wide range of corporate finance and securities transactions, including stock
market flotations, rights issues, securities regulation for public listed companies, mergers
and acquisitions, joint ventures, as well as general corporate advisory work. He is also a
member of Shook Lin & Bok LLP’s China practice group and has advised multinational
corporations and Singapore companies on cross border transactions in China, as well as
on public offerings of securities in Singapore by companies from China. He is also currently
an independent director of several other public listed companies on the SGX. He has been
cited by Chambers Asia as one of the leading corporate lawyers in Singapore for capital
markets.
